Remove 2019 Remove Leads Remove Side effects
article thumbnail

Influencer marketing in pharma

World of DTC Marketing

The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. Google Trends has reported that the top search terms for Wegovy besides weight loss are “Wegovy cost” and “Wegovy side effects.” Can pharma leverage influencer marketing? bilĀ­lion in 2021.

Marketing 192
article thumbnail

Novel anti-epileptic drug demonstrates efficacy

European Pharmaceutical Review

A new approach to potassium-channel openers for epilepsy Critically, XEN1101 combines the effectiveness of potassium-channel openers with the safety of more traditional drugs, stated study lead author and neurologist Dr Jacqueline French. It ran between January 2019 and September 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The fairytale of DTC TV ads

World of DTC Marketing

Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. According to a 2019 study from Kantar , a whopping 70 percent of consumers say they see the same ads over and over again. Running T.V. spots and instead come up with a unique way to reach their audience that works.

article thumbnail

Biogenā€™s Alzheimerā€™s drug: Whatā€™s the price tag on hope?

World of DTC Marketing

Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. Biogen concluded the key to effectiveness was giving patients a high-enough dose, but critics howled, with one calling the analysis ā€œa post hoc dumpster dive operation.ā€

FDA 187
article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen. Regarding both common cold and headache, they are as well among the side effects reported for similar drugs.

article thumbnail

Roche takes another punt on IL-2 in cancer with Good takeover

pharmaphorum

Good’s lead drug is due to start clinical testing next year. Foremost among those was Bristol-Myers Squibb and Nektar’s bempegaldesleukin, a pegylated form of recombinant IL-2 that aimed to extend the half-life of the cytokine in the body, extending the time between doses, and simultaneously reducing side effects.

article thumbnail

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

pharmaphorum

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.